These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1163834)

  • 1. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation.
    Bull MH; Huse WM; Bull BS
    Anesthesiology; 1975 Sep; 43(3):346-53. PubMed ID: 1163834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two methods for heparin monitoring: a semi-automated heparin monitoring device and activated clotting time during extracorporeal circulation.
    Stead SW
    Int J Clin Monit Comput; 1989 Dec; 6(4):247-54. PubMed ID: 2628513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of heparin concentration and activated clotting time monitoring (HEPCON HMS) system].
    Sakurada T; Kikuchi Y; Koushima R; Nakashima S; Hachiro Y; Kagaya H
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):836-40. PubMed ID: 9217380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of activated coagulation time in monitoring heparin therapy during extracorporeal circulation.
    Ottesen S; Stormorken H; Hatteland K
    Scand J Thorac Cardiovasc Surg; 1984; 18(2):123-8. PubMed ID: 6611586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations.
    Mattox KL; Guinn GA; Rubio PA; Beall AC
    Ann Thorac Surg; 1975 Jun; 19(6):634-8. PubMed ID: 1079715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haemochron--a simple method of monitoring heparin level during extracorporeal circulation].
    Saggau W; Lüllig H; Storch HH; Tanzeem A; Schmitz W; Hissen W
    Chir Forum Exp Klin Forsch; 1978; (1978):119-22. PubMed ID: 752575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated clotting time for control of anticoagulation during surgery.
    Lefemine AA; Lewis M
    Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
    Wallock M; Jeske WP; Bakhos M; Walenga JM
    Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of activated coagulation time to monitor heparin during cardiac surgery.
    Roth JA; Cukingnan RA; Scott CR
    Ann Thorac Surg; 1979 Jul; 28(1):69-72. PubMed ID: 454047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monitoring of heparin activity during extracorporeal circulation.
    Gomperts ED; Bethlehem B; Hockley J
    S Afr Med J; 1977 Jun; 51(26):973-6. PubMed ID: 888033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.
    Culliford AT; Gitel SN; Starr N; Thomas ST; Baumann FG; Wessler S; Spencer FC
    Ann Surg; 1981 Jan; 193(1):105-11. PubMed ID: 6970015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding.
    Kaul TK; Crow MJ; Rajah SM; Deverall PB; Watson DA
    J Thorac Cardiovasc Surg; 1979 Jul; 78(1):95-102. PubMed ID: 449391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery.
    Mabry CD; Thompson BW; Read RC
    Am J Surg; 1979 Dec; 138(6):894-900. PubMed ID: 507308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation monitoring correlation with heparin dose in pediatric extracorporeal life support.
    Moynihan K; Johnson K; Straney L; Stocker C; Anderson B; Venugopal P; Roy J
    Perfusion; 2017 Nov; 32(8):675-685. PubMed ID: 28693359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.